Increased mAb production in amplified CHO cell lines is associated with increased interaction of CREB1 with transgene promoter
Most therapeutic monoclonal antibodies in biopharmaceutical processes are produced in Chinese hamster ovary (CHO) cells. Technological advances have rendered the selection procedure for higher producers a robust protocol. However, information on molecular mechanisms that impart the property of hyper...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-11-01
|
Series: | Current Research in Biotechnology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590262819300061 |